Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Our history
Deletion of IL-4Rα in the BALB/c mouse is associated with altered lesion topography and susceptibility to experimental autoimmune encephalomyelitis.
[Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate].
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Nrf2 in health and disease: current and future clinical implications.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Increased risk of multiple sclerosis relapse after in vitro fertilisation.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Low-Voltage-Activated CaV3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles.
Simvastatin regulates oligodendroglial process dynamics and survival.
Glycans of myelin proteins.
Tysabri screening test may be unreliable
Carnitine for fatigue in multiple sclerosis.
Pain mechanisms in multiple sclerosis.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
227
228
229
230
231
232
233
234
235
…
next ›
last »